ENTITY

DBV Technologies SA (DBVT US)

1
Analysis
Health CareFrance
DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin.
more
Exchange Announcement31 Oct 2025 04:49
Exchange Announcement19 Sep 2025 04:42
Exchange Announcement06 Sep 2025 04:38
Exchange Announcement06 Sep 2025 04:06
x